Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
- Submitting institution
-
University of Nottingham, The
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 5030487
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736%2817%2932849-0
- Title of journal
- Lancet
- Article number
- -
- First page
- 850
- Volume
- 391
- Issue
- 10123
- ISSN
- 0140-6736
- Open access status
- Compliant
- Month of publication
- December
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
511
- Research group(s)
-
J - Rehabilitation Research
- Citation count
- 43
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to analysis and interpretation of study data
The author made a substantial contribution to carrying out the study
The author made a substantial contribution to the conception and design of the study
The author made a substantial contribution to the organisation of the conduct of the study
The author helped critique the output for important intellectual content
The author helped draft the output
- Non-English
- No
- English abstract
- -
